SOX2 and central nervous system cancer: Furthermore, the immunohistochemistry analysis of 17 glioma specimens revealed a notably higher incidence of positive expression for SOX2 and PIK3R3 in GBM tissues compared to I‐III glioma tissues (Figure 6I).